http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3930713-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8986c4f279d5f8fcb81496247ddd337a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
filingDate 2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b61ea294d852353d39f20b9f7daf676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_201d166fa05c7653fa80269409d2f16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b87961a45f41848fadcd2e6e19e4d44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1798332eee1b5c16d2c50baff80f8124
publicationDate 2022-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3930713-A1
titleOfInvention Stable tacrolimus ointment formulation for topical treatment of skin conditions
abstract The present invention provides a storage stable Tacrolimus ointment formulation comprising tacrolimus and propylene carbonate in a specific weight ratio and methods of preparing the same. More specifically, present invention relates to a pharmaceutical ointment composition comprising 0.1% or 0.03% (w/w) tacrolimus and 6.0% to 9.0% (w/w) propylene carbonate based on the total composition.
priorityDate 2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10149435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226634662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87090706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226655365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451324793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226655366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453620215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643

Total number of triples: 42.